Mannkind pressures drug stocks
February 11, 2011 at 11:39 AM EST
Shares of Mannkind Corp. sank 20% on news that it was laying off 41% of its workforce in order to focus its resources on its troubled inhaled insulin product Afrezza.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.